focus -WSS

focus

author：comprehensive 2025-09-27 23:32:04 - browse：67882

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Telehealth startups are trying to fill the menopause care vacuum

knowledge

entertainment

WSS

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Wegovy leads to weight loss. Can it treat depression, too?

Medicare drug price negotiation legal challenge met with skepticism

A new ‘biological computer' targets cancer while sparing healthy cells

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

The Affordable Care Act has saved billions in health care costs

hotspot

focus

focus

Hollywood unions extend contract negotiations for actors

Zyn nicotine pouches become unlikely player in latest culture war

Trump demands the U.S. pay no more for drugs than other countries … again

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

In Memoriam: Notable people who died in 2023

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Malaria cases in Florida and Texas: Here’s what you need to know

FTC sues over Novant Health acquisition of two N.C. hospitals

Medicare details structure of new drug price negotiation program

Sanders wants to replace patents with prizes for drug inventions

entertainment

'CMA Fest' 2023: How to watch, who is performing and more

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Why Medicare shouldn’t cover every FDA

Why Medicare shouldn’t cover every FDA

White House pharmacy plagued with problems, investigation finds

knowledge

hotspot

entertainment

focus